Calypso Biotech
Calypso Biotech
Chrysalis Unveils Fast Flexible Cleanroom Solutions!
Chrysalis launches with cleanroom assets! 🦋 Offering flexible manufacturing solutions in Massachusetts and North Carolina. 🏭 Tailored cleanrooms ready in 4-6 weeks! ⏳🚀
Biotech Revolution: AI Job Cuts and Breakthroughs!
**Excerpt:** 🌍 Discover how biotech is evolving with AI, job changes, and groundbreaking treatments! 🔬💊 Explore the future of DNA and sequencing! 🧬📊
Unlocking Early Success: Choose the Best Biologics!
Unlock the secrets to identifying top biologic candidates early! 🚀 Enhance decision-making with innovative strategies and efficient evaluations. 🔍🧬📊
Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing
📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.
Unlocking the Power of Industrial IoT in Bioprocessing
📰 The Industrial Internet of Things (IIoT) is revolutionizing bioprocessing, offering better control and streamlined regulatory submissions. 💪💰
AstraZeneca Acquires Amolyt Pharma for $105bn!
📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!
Bio-Techne’s CGT Boosts Growth: Q2 Success
📣 Bio-Techne Q2: CGT is a major growth driver! 🧪 Increasing demand, 💼 expanding capacity, and 💰 future growth expected.
Pfizer’s Bold Investment in Cancer Therapies
📢 Pfizer applauds its big bet in ADCs, a promising cancer treatment area, expecting long-term payoffs and therapeutic advancements. 💪🏥🩺
Revolutionizing Bioprocessing with IoT Innovation
🌐💡 The IoT can revolutionize bioprocessing by connecting devices and exchanging data, leading to more efficient experiments and automation. 🚀
Resilience Teams Up with VGXI for pDNA Supply
Resilience 📢 selects VGXI 🤝 for pDNA supply, fostering promising partnership in the 🧪 biotech industry. Resilience VGXI biotech
